Georges Vauquelin, Yvette Michotte, Ilse Smolders, Sophie Sarre, Guy Ebinger, Alain Dupont, and Patrick Vanderheyden

Cellular targets for angiotensin II fragments: pharmacological and molecular evidence
J Renin Angiotensin Aldosterone Syst 2002 3: 195-204. [Abstract] [PDF] [References]  

Gozewijn D Laverman, Dick de Zeeuw, and Gerjan Navis

Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy?
J Renin Angiotensin Aldosterone Syst 2002 3: 205-213. [Abstract] [PDF] [References]  

Scott M MacKenzie, Robert Fraser, John MC Connell, and Eleanor Davies

Local renin-angiotensin systems and their interactions with extra-adrenal corticosteroid production
J Renin Angiotensin Aldosterone Syst 2002 3: 214-221. [Abstract] [PDF] [References]  

Løgstrup Poulsen

Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes
J Renin Angiotensin Aldosterone Syst 2002 3: 222-242. [Abstract] [PDF] [References]  

W David Strain and Nish Chaturvedi

Review: The renin-angiotensin-aldosterone system and the eye in diabetes
J Renin Angiotensin Aldosterone Syst 2002 3: 243-246. [Abstract] [PDF] [References]  

Domenic A Sica and Todd WB Gehr

Review: The pharmacokinetics and pharmacodynamics of angiotensin-receptor blockers in end-stage renal disease
J Renin Angiotensin Aldosterone Syst 2002 3: 247-254. [Abstract] [PDF] [References]  

The DIRECT Programme Study Group and Nish Chaturvedi

The DIabetic Retinopathy Candesartan Trials (DIRECT) Programme, rationale and study design
J Renin Angiotensin Aldosterone Syst 2002 3: 255-261. [Abstract] [PDF] [References]  

Michael Mauer, Bernard Zinman, Robert Gardiner, Keith N Drummond, Samy Suissa, Sandra M Donnelly, Trudy D Strand, Michael S Kramer, Ronald Klein, and Alan R Sinaiko

ACE-I and ARBs in early diabetic nephropathy
J Renin Angiotensin Aldosterone Syst 2002 3: 262-269. [Abstract] [PDF] [References]  

Pacific Study Group and Bruce Neal

Effects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart disease
J Renin Angiotensin Aldosterone Syst 2002 3: 270-276. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.